Results 51 to 60 of about 12,611 (222)

Typical simulated PWID network with 274 nodes.

, 2013
Typical simulated PWID network with 274 nodes.
Emma McBryde (392529), Margaret Hellard (124059), Rebecca Jenkinson (124030), Garry Robins (124040), David A. Rolls (478964), Rachel Sacks-Davis (124007), Philippa Pattison (124036)   +6 more
core   +1 more source

PrEP Cascade among PWID accessing SSP in Miami, FL.

, 2020
PrEP Cascade among PWID accessing SSP in Miami, FL.
David W. Forrest (8720265), Young Jo (8720259), Allan Rodriguez (3858568), Susanne Doblecki-Lewis (755194), Jasmine Tomita-Barber (8720268), Hansel E. Tookes (8720274), Juan Oves (8720271), Tyler S. Bartholomew (8720262)   +7 more
core   +1 more source

Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India

Harm Reduction Journal, 2017
Background WHO, UNODC, and UNAIDS recommend a comprehensive package for prevention, treatment, and care of HIV among people who inject drugs (PWID).
Mary Philip Sebastian, Aparajita Dasgupta, Lopamudra Ray Saraswati, Asha Singh, Vartika Sharma, Ira Madan, Waimar Tun, Julie Pulerwitz, Ibou Thior, Avina Sarna   +9 more
doaj   +1 more source

The harm reduction shift: A review of India's NACP strategies for PWID

Bioinformation
India's HIV epidemic is highly concentrated among People Who Inject Drugs (PWID) and who exhibits the highest prevalence among key populations despite decades of intervention. The Review highlights a policy shift from awareness-based campaigns in NACP-I to Targeted Interventions in NACP-II, the three-tier harm-reduction model including Opioid ...
Prajapat, Kapil, Hassan, Fathima, Chamayi, Lulu Sirin, Koduvayalil, Rislaj Hameed, Das, Ankit, Jinjala, Darshit Samatbhai, Joshi, Vedant Mukul   +6 more
openaire   +2 more sources

Longitudinal changes in readily available inflammatory markers before and after switching to integrase inhibitor‐based antiretroviral therapy in Virologically suppressed people living with HIV: A Nationwide real‐world cohort study

HIV Medicine, EarlyView.
Abstract Background Persistent immune activation and systemic inflammation remain key features of chronic HIV infection despite sustained virological suppression under antiretroviral therapy (ART), contributing to excess non‐AIDS morbidity and mortality.
Stelios F. Assimakopoulos, Achilleas Stamoulopoulos, Mina Psichogiou, Varvara Vasalou, Vasileios Papastamopoulos, Antonis Papadopoulos, Georgios Adamis, Maria Chini, Simeon Metallidis, Georgios Loizos, Lydia Leonidou, Helen Sambatakou, Markos Marangos, Diamantis Kofteridis, Giota Touloumi, on behalf of AMACS, G. Adamis, M. Chini, G. Chrysos, M. Marangos, O. Katsarou, D. Kofteridis, S. Metallidis, P. Panagopoulos, N. Pantazis, A. Papadopoulos, V. Paprizos, V. Papastamopoulos, M. Psichogiou, H. Sambatakou, NV. Sipsas, G. Touloumi, G. Touloumi, N. Pantazis, C. Thomadakis, A Stamoulopoulos, A Papadopoulos, A Antoniadou, C Protopapas, D Kavatha, G Chrysos, T Nitsotolis, M Psichogiou, E Mastrogianni, G Adamis, M Astriti, MN Marangos, L Leonidou, O Katsarou, A Kouramba, NV Sipsas, A Kontos, D Basoulis, M Chini, G Tsekes, N Mangafas, S Metallidis, O Tsachouridou, Τ Chrysanthidis, V Paparizos, V Vasalou, S Kourkounti, H Sambatakou, V Papastamopoulos, G Lourida, P Panagopoulos, V Petrakis, D Kofteridis, K Alexakis, V Malikidis, H Gogos, M Psichogiou   +71 more
wiley   +1 more source

Epidemiology and health burden of infective endocarditis: a comparative analysis of Australian vs global trends from 1990 to 2021

Internal Medicine Journal, EarlyView.
Abstract Background Infective endocarditis (IE) is an uncommon but life‐threatening disease with evolving patient risk profiles and management strategies. However, its impact on the Australian healthcare system has not been described. Aims To quantify the healthcare burden of IE in Australia over time in the past three decades and compare outcomes with
David M. Chye, Kate L. Drummond, Thalys Sampaio Rodrigues, Elizabeth Paratz, Robert Horvath, Eugene Athan, Louise M. Burrell, Natasha E. Holmes, Olivia C. Smibert, Anoop N. Koshy   +9 more
wiley   +1 more source

Estimated HIV Prevalence among PWID and Non-PWID.

, 2015
HHRP+: Holistic Health Recovery Program for HIV+; HIV: human immunodeficiency virus; OST: opioid substitution therapy; PWID: people who inject drugs; 3H+: Holistic Health for HIV.
Michael M. Copenhaver (690060), Frederick L. Altice (256777), Elisa F. Long (195953), Dahye L. Song (690059)   +3 more
core   +1 more source

HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming

Harm Reduction Journal, 2019
Background There is a dearth of evidence on injecting drug use and associated HIV and hepatitis C virus (HCV) infections in Uganda. As such, policy and programming for people who inject drugs (PWID) is limited due to scarcity of epidemiological data.
Matayo Baluku, Twaibu Wamala, Denis Muhangi   +2 more
doaj   +1 more source

Non–AIDS‐Defining Cancer Incidence in People With HIV in Milan, Italy, 2000–2023: Temporal Trends and Comparison With the General Population

International Journal of Cancer, Volume 159, Issue 12, Page 2870-2876, 15 December 2026.
ABSTRACT People with HIV (PWH) are living longer, but contemporary data on non–AIDS‐defining cancers (NADCs) in Italy remain limited. We assessed incident cancers in a retrospective cohort of PWH in Milan, Italy, between January 2000 and December 2023. Follow‐up was grouped into 2000–2007, 2008–2015, and 2016–2023. Incidence rates (IRs) were calculated
Giacomo Pozza, Maddalena Matone, Letizia Oreni, Giorgia Carrozzo, Beatrice Caloni, Maria Vittoria Cossu, Davide Moschese, Anna Lisa Ridolfo, Cristina Gervasoni, Cinzia Fasola, Nicla La Verde, Davide Dalu, Spinello Antinori, Andrea Gori, Andrea Giacomelli   +14 more
wiley   +1 more source

Implementation of a bundle to improve HIV testing during hospitalization for people who inject drugs

Implementation Research and Practice, 2023
Background Increased HIV testing is essential to ending the HIV epidemic. People who inject drugs (PWID) are among the highest risk for HIV infection. Previous research at Tufts Medical Center identified low HIV testing rates in hospitalized PWID.
Emily D. Grussing, Bridget Pickard, Ayesha Khalid, Emma Smyth, Victoria Childs, Julia Zubiago, Hector Nunez, Amanda Jung, Yoelkys Morales, Denise H. Daudelin, Alysse G. Wurcel   +10 more
doaj   +1 more source